Stock earnings page

VistaGen Therapeutics, Inc. (VTGN)

Track the next or latest earnings date for VistaGen Therapeutics, Inc., review consensus estimates, and see cached AI analysis for recent quarterly results.

View this earnings week Open in the app

Recent earnings news

Is Vistagen Therapeutics, Inc. (VTGN) a Breakout Anxiety Drug Stock After New Phase 3 Extension Results? - Insider Monkey
www.insidermonkey.com · 4 days ago

READ NEXT: 8 Most Oversold Large Cap Stocks to Buy and 10 Best Cancer Stocks to Buy for the Long Term. Disclosure: None. Follow Insider Monkey on Google News. NASDAQ:VTGNYahoo FinanceVistaGen Therapeutics Inc. (NASDAQ:VTGN) ... VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q1 2026 Earnings Call ...

VistaGen Appoints New Chief Medical Officer to Advance Pipeline - TipRanks.com
www.tipranks.com · 3 days ago

To see the full list of analyst ... the VTGN Stock Forecast page. ... According to Spark, TipRanks’ AI Analyst, VTGN is a Neutral. The score is held down primarily by weak financial performance (large losses and significant ongoing cash burn on very small revenue) and longer-term bearish technical p…

Vistagen appoints Angel Angelov as chief medical officer By Investing.com
ca.investing.com · 4 days ago

SOUTH SAN FRANCISCO, Calif. - Vistagen (NASDAQ:VTGN) announced Monday the appointment of Angel S.

Buy VistaGen Therapeutics Stock – VTGN Stock Quote Today & Investment Insights - Public.com
public.com · Recent

Looking to buy VistaGen Therapeutics Stock? Get the latest VTGN quote, news, earnings, forecast, price targets, and market insights. Start investing on Public.com.

Assessing Venture Global (VG) Valuation After Q1 Earnings Beat And New LNG Supply Deals - Simply Wall St News
simplywall.st · 1 week ago

Venture Global (VG) moved into the spotlight after Q1 2026 results beat earnings and revenue estimates, paired with higher adjusted EBITDA guidance and fresh LNG supply deals with buyers including TotalEnergies and Vitol. See our latest analysis for Venture Global.

Latest earnings date

Feb 12, 2026

Time not specified

Fiscal quarter: Dec/2025

EPS estimate: -$0.50

Revenue estimate: N/A

Market cap: $22.14M

Analysis snapshot

No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.

Recent earnings history

Browse the calendar week

Date	Quarter	Report window	EPS est.	Revenue est.
Feb 12, 2026	Dec/2025	Time not specified	-$0.50	N/A